Synthesis of lipoamino acids and their activity against cerebral ischemic injury

Molecules

Volumn 14, Issue 10, 2009, Pages 4051-4064

  Yao, Li Yun ^a   Lin, Qi ^a   Niu, Yin Yao ^a   Deng, Ke Min ^a   Zhang, Jian Hua ^a   Lu, Yang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Brain ischemia; Lipoamino acids; Neuroprotection; Oxygen glucose deprivation

Indexed keywords

DRUG DERIVATIVE; HYDROGEN PEROXIDE; N STEAROYL L SERINE; N STEAROYL L THREONINE; N STEAROYLTYROSINE; N-STEAROYL-L-SERINE; N-STEAROYL-L-THREONINE; N-STEAROYLTYROSINE; NEUROPROTECTIVE AGENT; SERINE; THREONINE; TYROSINE;

ANAEROBIC GROWTH; ANIMAL; ARTICLE; BRAIN; BRAIN ISCHEMIA; CHEMISTRY; DRUG EFFECT; RAT; SYNTHESIS; VASCULARIZATION;

ANAEROBIOSIS; ANIMALS; BRAIN; BRAIN ISCHEMIA; HYDROGEN PEROXIDE; NEUROPROTECTIVE AGENTS; RATS; SERINE; THREONINE; TYROSINE;

EID: 70350518984     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14104051     Document Type: Article

References (28)

1. Harukuni, I.; Bhardwaj, A. Mechanisms of brain injury after global cerebral ischemia. Neurol. Clin. 2006, 24, 1-21.
2. Ong, W.Y.; Farooqui, A.A. Iron, neuroinflammation, and Alzheimer's disease. J. Alzheimers Dis. 2005, 8, 183-200.
3. Mosley, R.L.; Benner, E.J.; Kadiu, I.; Thomas, M.; Boska, M.D.; Hasan, K.; Laurie, C.; Gendelman, H.E. Neuroinflammation, oxidative stress and the pathogenesis of Parkinson's disease. Clin. Neurosci. Res. 2006, 6, 261-281.
4. Pérez de la Ossa, N.; Dávalos, A. Neuroprotection in cerebral infarction: the opportunity of new studies. Cerebrovasc. Dis. 2007, 24, 153-156.
5. LinksPoewe, W. The need for neuroprotective therapies in Parkinson's disease: A clinical perspective. Neurology 2006, 66, 2-9.
6. Golde, T.E. The therapeutic importance of understanding mechanisms of neuronal cell death in neurodegenerative disease. Mol. Neurodegener. 2009, 4, 8-13
7. Zhou, M.; Xu, W.; Liao, G.H.; Bi, X.N.; Baudry, M. Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation. Exp. Neurol. 2009, 218, 75-82.
8. Abe, K. Neuroprotective therapy for ischemic stroke with free radical scavenger and gene-stem cell therapy. Rinsho Shinkeigaku 2008, 48, 896-898.
9. Bye, N.; Habgood, M.D.; Callaway, J.K.; Malakooti, N.; Potter, A.; Kossmann, T.; Morganti-Kossmann, M.C. Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp. Neurol. 2007, 204, 220-233.
10. Ginsberg, M.D. Neuroprotection for ischemic stroke: Past, present and future. Neuropharmacology 2008, 55, 363-389.
11. Galve-Roperh, I.; Aguado, T.; Rueda, D.; Velasco, G.; Guzmán, M. Endocannabinoids: A new family of lipid mediators involved in the regulation of neural cell development. Curr. Pharm. Des. 2006, 12, 2319-2325.
12. Micale, V.; Mazzola, C.; Drago, F. Endocannabinoids and neurodegenerative diseases. Pharmacol. Res. 2007, 56, 382-392.
13. Bahr, B.A.; Karanian, D.A.; Makanji, S.S.; Makriyannis, A. Targeting the endocannabinoid system in treating brain disorders. Expert. Opin. Investig. Drugs 2006, 15, 351-365.
14. Burstein, S. The elmiric acids: Biologically active anandamide analogs. Neuropharmacology 2008, 55, 1259-1264.
15. Burstein, S.H.; Adams, J.K.; Bradshaw, H.B.; Fraioli, C.; Rossetti, R.G.; Salmonsen, R.A.; Shaw, J.W.; Walker, J.M.; Zipkin, R.E.; Zurier, R.B. Potential anti-inflammatory actions of the elmiric (lipoamino) acids. Bioorg. Med. Chem. 2007, 15, 3345-3355.
16. Huang, S.M.; Bisogno, T.; Petros, T.J.; Chang, S.Y.; Zavitsanos, P.A.; Zipkin, R.E.; Sivakumar, R.; Coop, A.; Maeda, D.Y.; De Petrocellis, L.; Burstein, S.; Di Marzo, V.; Walker, J.M. Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J. Biol. Chem. 2001, 276, 42639-42644.
17. Wang, Z.J.; Li, G.M.; Nie, B.M.; Lu, Y.; Yin, M. Neuroprotective effect of the stearic acid against oxidative stress via phosphatidylinositol 3-kinase pathway. Chem. Biol. Interact. 2006, 160, 80-87.
18. Blumberg, S.; Vallee, B.L. Superactivation of thermolysin by acylation with amino acid Nhydroxysuccinimide esters. Biochem. 1975, 14, 2410-2419.
19. Mckennon, M.J.; Meyers, A.I.; Drauz, K.; Schwarm M. A convenient reduction of amino acids and their derivatives. J. Org. Chem. 1993, 58, 3568-3571.
20. 2. J. Org. Chem. 1991, 56, 5964-5965.
21. Xue, Q.S.; Yu, B.W.; Wang, Z.J.; Chen, H.Z. Effects of ketamine, midazolam, thiopental, and propofol on brain ischemia injury in rat cerebral cortical slices. Acta. Pharmacol. Sin. 2004, 25, 115-120.
22. Lipton, P. Ischemic cell death in brain neurons. Physiol. Rev. 1999, 79, 1431-1568.
23. Mathew, K.S.; McLaughlin, D.P.; Ziabari, L.H.; Toner, C.C.; Street, P.C.; Hisgrove, E.; Bezzina, E.L.; Stamford, J.A. Rapid quantification of ischemic injury cerebroprotection in brain slices using densitometric assessment of 2,3,5-triphenyltetrazolium chloride staining. J. Neurosci. Methods 2000, 102, 43-51.
24. Tureyen, K.; Vemuganti, R.; Sailor, K.A.; Dempsey, R.J. Infarct volume quantification in mouse focal cerebral ischemia: A comparison of triphenyltetrazolium chloride and cresyl violet staining techniques. J. Neurosci. Methods 2004, 139, 203-207.
25. Toner, C.C.; Miline, A.J.; Blatchford, K.L.; McLaughlin, D.P.; Stamford, J.A. An assessment of the cerebroprotective potential of volatile anaesthetics using two independent methods in an in vitro model of cerebral ischemia. Brain Res. 2002, 958, 390-398.
26. Bickler, P.E.; Hansen, B.M. Hypoxia-tolerant neonatal CA1 neurons: relationship of survival to evoked glutamate release and glutamate receptor-mediated calcium changes in hippocampal slices. Brain Res. Dev. Brain Res. 1998, 106, 57-69.
27. Zhang, Y.B.; Kan, M.Y.; Yang, Z.H.; Ding, W.L.; Yi, J.; Chen, H.Z.; Lu, Y. Neuroprotective effects of N-stearoyltyrosine on transient global cerebral ischemia in gerbils. Brain Res. 2009, 1287, 146-156.
28. Anderson, G.W.; Zimmerman, J.E.; Callahan, F.M. The use of esters of N-hydroxysuccinimide in peptide synthesis. J. Am. Chem. Soc. 1964, 86, 1839-1842.